as 08-01-2025 4:00pm EST
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Founded: | 1983 | Country: | United States |
Employees: | N/A | City: | CHICAGO |
Market Cap: | 28.6B | IPO Year: | 1998 |
Target Price: | $72.67 | AVG Volume (30 days): | 2.7M |
Analyst Decision: | Buy | Number of Analysts: | 9 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 0.43 | EPS Growth: | N/A |
52 Week Low/High: | $54.68 - $71.36 | Next Earning Date: | 07-30-2025 |
Revenue: | $5,267,088,000 | Revenue Growth: | 11.91% |
Revenue Growth (this year): | 14.58% | Revenue Growth (next year): | 8.68% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Roberts Carey S. | VTR | EVP and GC | May 30 '25 | Sell | $64.23 | 23,500 | $1,509,447.30 | 116,650 | |
Probst Robert F | VTR | EVP and CFO | May 27 '25 | Sell | $65.22 | 17,374 | $1,133,139.23 | 168,364 | |
Probst Robert F | VTR | EVP and CFO | May 21 '25 | Sell | $64.59 | 69,592 | $4,495,212.40 | 168,364 | |
RAKOWICH WALTER C | VTR | Director | May 13 '25 | Sell | $63.76 | 1,459 | $93,025.69 | 27,454 |
VTR Breaking Stock News: Dive into VTR Ticker-Specific Updates for Smart Investing
Zacks
a month ago
Morningstar Research
a month ago
MT Newswires
a month ago
Barchart
a month ago
Benzinga
2 months ago
MT Newswires
2 months ago
Zacks
2 months ago
Zacks
2 months ago
The information presented on this page, "VTR Ventas Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.